Cardiac Troponin T After Transcatheter Closure of the Interatrial Septum

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03099967

Enrollment

Registered

2017-04-04

Start date

2005-01-01

Completion date

2017-01-01

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

To examine retrospectively whether transcatheter closure of the interatrial septum leads to myocardial injury and to determine the mechanism.

Detailed description

In a prospective study in adults troponin T (TnT) serum concentrations were determined before and the day after transcatheter closure of an atrial septal defect (ASD) or patent foramen ovale (PFO).

Interventions

DEVICETranscatheter closure of an atrial septal defect or patent foramen ovale.

In a prospective study in adults troponin T (TnT) serum concentrations were determined before and the day after transcatheter closure of an atrial septal defect (ASD) or patent foramen ovale (PFO).

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* transcatheter ASD and PFO closure at the University Hospital of Lund, Sweden

Exclusion criteria

* missing TnT values

Design outcomes

Primary

Measure	Time frame
TnT changes	Blood samples for TnT were taken one day before intervention and one day after intervention.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026